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Abstract
Three members of the d-endotoxin group of toxins expressed by Bacillus thuringiensis subsp. israelensis, Cyt2Ba, Cry4Aa and
Cry11A, were individually expressed in recombinant acrystalliferous B. thuringiensis strains for in vitro evaluation of their
toxic activities against insect and mammalian cell lines. Both Cry4Aa and Cry11A toxins, activated with either trypsin or
Spodoptera frugiperda gastric juice (GJ), resulted in different cleavage patterns for the activated toxins as seen by SDS-PAGE.
The GJ-processed proteins were not cytotoxic to insect cell cultures. On the other hand, the combination of the trypsin-
activated Cry4Aa and Cry11A toxins yielded the highest levels of cytotoxicity to all insect cells tested. The combination of
activated Cyt2Ba and Cry11A also showed higher toxic activity than that of toxins activated individually. When activated
Cry4Aa, Cry11A and Cyt2Ba were used simultaneously in the same assay a decrease in toxic activity was observed in all
insect cells tested. No toxic effect was observed for the trypsin-activated Cry toxins in mammalian cells, but activated Cyt2Ba
was toxic to human breast cancer cells (MCF-7) when tested at 20 mg/mL.
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Introduction
Crop-damaging insects are responsible for a significant decrease
in world crop yields every year [1]. Insects are also important
vectors of human disease and thus are the focus of considerable
control efforts [2]. The use of biological control of insects has been
shown to be a safe, successful, cost-effective and promising
alternative to chemical control [3]. The gram-positive, spore-
forming bacterium Bacillus thuringiensis (Bt), which occurs naturally
in several environments [4], is largely employed in biological
control of various insect pests. Different Bt subspecies are toxic to
specific insect groups, producing, during the sporulation phase,
crystalline inclusion bodies consisting of host-specific insecticidal
Cry and/or Cyt proteins known as d-endotoxins [5]. Due to the
high specificity to target insects and little evidence of toxicity to
vertebrates and plants, the use of Bt as an alternative to chemical
insect control has increased greatly [6]. Cry protoxins are
solubilized under alkaline pH in the insect midgut and activated
by endogenous gut proteases; these protoxins then interact with
specific receptors present in the epithelial cells of the insect midgut,
causing pore formation and consequent osmotic cell lysis [7,5].
Cyt protoxins also need solubilization and proteolytic cleavage in
the insect’s midgut to become active, but in contrast to Cry toxins,
Cyt proteins bind nonspecifically to unsaturated phospholipids
present in the host’s epithelial cell, forming pores [8] or disrupting
the membrane through a detergent-like mode of action [9].
Relevant differences in the midgut physiology and consequent
variation in proteolytic activity among different insect orders may
determine the specificity of each toxin. For example, the main
digestive lepidopteran and dipteran proteases are serine-proteases,
whereas those found in coleoptera are cysteine and aspartic-
proteases [10]. Cyt proteins are toxic to mosquito larvae, although
their toxicities are usually lower than those from Cry proteins toxic
to dipteran larvae [11]. It has also been reported that native toxins
belonging to the Cyt family are toxic in vitro to erythrocytes and
other mammalian cells, and lethal to mice after intravenous
injection [12–15]. Cyt toxins have been shown to act synergisti-
cally with mosquitocidal Cry toxins [16]; Cyt1Aa can, for
example, function as a receptor for the binding of Cry11Aa to
Aedes aegypti gut cell membranes [17], thus playing a crucial role in
the general activity of the parasporal inclusion. Bacillus thuringiensis
subsp. israelensis (Bti) is highly toxic to dipteran insects and is
utilized in mosquito control in many countries [18] e.g., to combat
malaria and dengue fever. The entomopathogenic activity of Bti
for Culex spp, Aedes spp and Anopheles spp is due to the presence of
a megaplasmid, pBtoxis, which encodes at least four Cry and two
Cyt toxins: Cry4Aa, Cry4Ba, Cry10, Cry11Aa, Cyt1Aa and
Cyt2Ba [19]. This plasmid also contains coding sequences for two
other proteins (P19 and P20) believed to act as chaperones,
helping toxin crystal formation [19].
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In our study acrystalliferous Bt strains were engineered to
individually express Cry4Aa, Cry11A and Cyt2Ba proteins; the
strains could then be tested in vitro against different cultured cell
lines to determine their individual toxic activity and possible




Blast analysis of the sequences from amplified Bti genes showed
that the cyt2Ba gene was identical to the sequence described
elsewhere [20] (Genbank accession number = U52043), except for
a 6xHis tag sequence in the N-terminal end, introduced by a PCR
primer. The cry11A gene showed 100% nucleotide sequence
identity with the cry11A gene described earlier by Berry et al. [19]
(Genbank accession number = AL731825). The cry4Aa gene
showed 98% nucleotide sequence identity with the first described
cry4Aa gene [21] (Genbank accession number = Y00423) with eight
nucleotide base differences, resulting in eight amino acid changes
at the following positions: S16T, E32G, T301P, F569L, H572R,
D980N, F1168V, I1170K.
Expression, Purification and Solubilization of Cyt and Cry
Toxins
The amplified DNA fragments containing the cyt2BaHis, cry11A
and cry4Aa coding sequences were first cloned in a PCR cloning
vector (not shown), then transferred to the binary B. thuringiensis
expression vector pSVP27A under control of the sporulation phase
promoter Pcyt (Figures 1A, B, and C). The recombinant plasmids
were purified and inserted into an acrystalliferous Bt by
electroporation, giving rise to the recombinant BtCyt2BaHis,
BtCry11A and BtCry4Aa strains. The recombinant colonies were
grown in selective media for 72 h and the spore/crystal of the
mixture was subjected to centrifugation in discontinuous sucrose
gradients.
After purification, Cry11A and Cry4Aa crystals were solubilized
and analyzed by SDS-PAGE. Protein bands with the expected
molecular masses were detected (66 kDa and 130 kDa, re-
spectively) (Figure 1D). Despite the absence of the accessory
proteins P20 and P19, usually associated with the folding of
Cry11A, the recombinant Cry11A protein was largely expressed
with the expected molecular mass. Xu et al. [22] have shown that
the Cry11A protein was successfully expressed in recombinant E.
coli, in the presence or absence of P20. On the other hand, in
another recombinant Gram-negative bacterium, Pseudomonas
putida, the Cry11A protein was produced in satisfactory amounts
only when P20 was co-expressed [22]. Furthermore, high levels of
Cry11A expression and toxic activity against A. aegypti larvae were
shown in a recombinant acrystalliferous Bt strain, 4Q2-81 [18]. In
our work the Cyt2BaHis protein was obtained by centrifugation of
the recombinant Bt extracts in a discontinuous sucrose gradient,
followed by solubilization with Na2CO3 and affinity chromatog-
raphy due to the large number of contaminants present after
centrifugation (data not shown). After this additional purification
step, SDS-PAGE analysis was carried out, showing a single 27 kDa
band as expected (Figure 1E).
Toxicity of Dipteran-specific Cry4Aa and Cry11A Proteins
to Dipteran and Lepidopteran Cell Lines
Cry4Aa and Cry11A proteins have been shown to be toxic to
mosquitoes in vivo [4,23,24,25]. Our study used these two d-
endotoxins in cytotoxicity assays against both lepidopteran and
dipteran cell cultures. Solubilized and trypsin-activated Cry4Aa
and Cry11A toxins were incubated, separately or in combination,
with dipteran and lepidopteran cells. Use of equal amounts of
Cry4Aa and Cry11A toxin (20 mg/mL) resulted in similar toxic
effects in all cells tested. A slightly significant difference in toxicity
was observed only when the toxins were tested separately against
lepidopteran IPLB-SF-21AE and IPLB-LD-652Y cells. Interest-
ingly, the mixture of the two toxins showed higher toxic activity to
all insect cell lines (Figure 2A). In contrast, Chilcott and Ellar [26]
observed no cytotoxicity when incubating trypsin-activated 130
kDa and 65 kDa Bti proteins with a cell line derived from A.
albopictus. In our assays, the Cry4Aa and Cry11A activated toxins
showed 10 to 15% of the toxicity of wild type Bti-activated toxins
(see below) in A. albopictus C6/36 cells. Furthermore, the mixture of
the two recombinant proteins increased toxicity to approximately
36% of the wild type Bti-activated toxins. As reported earlier [27],
different cell lines from Choristoneura fumiferana (spruce budworm)
Figure 1. Schematic linear representation of the expression
plasmids and SDS-PAGE analysis of Cry11A, Cry4Aa and
Cyt2Ba expression. Panels A, B and C: cyt2BaHis, cry4Aa and cry11A
genes inserted, respectively, into the BamHI cloning site of the pSVP27A
plasmid. The recombinant genes are under the control of a sporulation
phase promoter, Pcyt. The genes for positive clone selection in E. coli
(Amp-r) and in B. thuringiensis (CAT-r) are shown. Selected restriction
enzyme sites used to confirm cloning are also shown. Panels D and E:
SDS-PAGE of purified protoxins (Cry11A, Cry4Aa and Cyt2Ba) from
recombinant B. thuringiensis strains. As a control, a sporulated
acrystaliferous B. thuringiensis strain (4Q7) extract was used. Selected
molecular masses of the protein markers are shown (ColorPlusTM
Prestained Marker-NEB, panel D and BenchMarkTM Protein Ladder-
Invitrogen, Panel E) on the left side of both panels.
doi:10.1371/journal.pone.0046121.g001
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showed distinct relative susceptibility when incubated with Bt
activated d-endotoxins. The presence, absence or availability of
suitable receptors on the cell surface could explain the diverse
levels of susceptibility among different cell lines deriving from one
insect species. The increased toxicity of combined Cry4Aa and
Cry11A to A. albopictus cells was also observed in previous research
[18]. The earlier study showed lower individual toxicity for
Cry4Ba, Cry4Aa and Cry11Aa proteins to fourth-instar A. aegypti
than native crystals produced by Bti. Sauka et al. [28] demon-
strated that a mixture of Cry1Ba and Cry1Da toxins yielded
a synergism factor higher than 1 [29] when tested against neonate
larvae of Epinotia aporema (bean shoot borer), suggesting a possible
synergism between these Cry toxins. However, no synergistic
interaction between 130kDa and 65 kDa Cry proteins was
detected in vivo against A. aegypti larvae [26,29]. Although Cry4Aa
and Cry11A protoxins used in our work may share the same
molecular mass as the respective proteins reported previously by
other research groups, they are not the same polypeptides; there
may be differences in the specificity of the molecular interactions.
Using a model for synergism proposed by Tabashnik [29], we
calculated the synergism factor (SF) for the Cry4Aa and Cry11A
mixture in all cell lines tested. For this purpose, the median lethal
concentration (LC50) was estimated (Table 1). For the dipteran
C6/36 and the lepidopteran SF-21 cell lines, the SF was higher
than 1, suggesting possible synergistic effects (Table 2). Poncet et al.
[30] detected higher SF values, and thus, stronger synergism when
using a mixture consisting of Cry4A and Cry11A against three
different species of mosquito larvae. The dipteran cell line used in
our assays, in vitro, is not necessarily derived from the midgut, but
from a minced A. albopictus larvae. In contrast, the SF was lower
than 1 for the mixture with the other two lepidopteran cell lines
tested (Ld and Bm5) and some antagonism was detected (Table 2).
Purified crystals from wild type Bti, containing all the d-endotoxins
expressed by this bacterium, were solubilized and added separately
to the cell cultures at a concentration of 5 mg/mL. This amount of
solubilized protein caused 100% cell lysis (data not shown) and was
used as a positive reference in the cytotoxicity studies.
Cyt2Ba Cytotoxicity to Insect Cells
Although Cyt toxins are produced by some dipteran-specific Bt
strains [31,32], these toxins have been reported to be cytolytic to
a broad range of cells [12]. To determine any possible relationship
between dose and toxicity to different cell lines, we activated
purified Cyt2Ba toxin (Figure 2B), which has been proposed to
bind cell membranes in a non-specific manner [8], and incubated
it with four types of insect cells using two different concentrations
(5 or 20 mg/mL). As demonstrated in our assays, Cyt2Ba showed
toxicity to all insect cells tested (Figure 2C). There was also
a significant increase in the toxic activity when Cyt2Ba was used at
a concentration of 20 mg/mL.
Incubation of Cell Lines with Both Cry and Cyt Toxins
To verify that Cyt2Ba and Cry toxins (Cry4A and Cry11A)
interact cytotoxically, assays were performed using combinations
Figure 2. Cytotoxicity assays in insect cell cultures and western blot analysis of Cyt2Ba activation. Panel A: 20 mg/mL of each activated
toxin, Cry4Aa and Cry11A, were incubated with different insect cell lines for 30 min. Untreated cells (control) were not incubated with any of the
toxins. The percentage of cytotoxicity (cell mortality) was determined by luminometric readings based on luciferase activity. Panel B: Trypsin
activation of Cyt2BaHis was proceeded and both protoxin and the activated toxin samples were analyzed by western blot with an anti-His antibody.
The arrow shows a band of 27 kDa expected for the non-activated protein. The proteolytic cleavage of Cyt2BaHis resulted in the 6xHis tag loss,
making the activated toxin undetectable in western blot analysis using anti-His antibody. Panel C: The activated Cyt2Ba toxin was incubated with
insect cells at two different concentrations (5 and 20 mg/mL). Cytotoxicity was determined as for panel A. Panel D: Combinations of Cyt2Ba (5 mg/mL)
and the two Cry toxins (20 mg/mL for each toxin) were incubated with insect cell lines. Cytotoxicity percentages were measured according to the
same method employed in panel A and C. The toxins concentrations are shown in brackets. One type of dipteran cells (C6/36) and three types of
lepidopteran cells (Ld, Sf-21 and Bm) are shown on the cytotoxicity assays graphics.
doi:10.1371/journal.pone.0046121.g002
Citotoxicity of d-Endotoxins to Different Cells
PLOS ONE | www.plosone.org 3 September 2012 | Volume 7 | Issue 9 | e46121
of these toxins. The Cry toxins were used at a concentration of
20 mg/mL, whereas the Cyt2Ba toxin was used at 5 mg/mL, since
any increase in the obtained cytotoxicity could be misinterpreted
as activity of only Cyt2Ba at its highest concentration
(Figure 2C).The data showed a higher level of toxic activity when
Cry11A and Cyt2Ba were used in combination (Figure 2D). In all
cells tested the toxicity demonstrated by this combination was
significantly higher than the Cry4Aa and Cyt2Ba combination
(Figure 2D). Nevertheless, in both cases different types of toxic
interactions were observed when determining the LC50 of the
mixtures and calculation of SF values (Tables 1 and 2). SF .1 was
achieved with the mixture Cyt2Ba/Cry11A in dipteran C6/36
and lepidopteran Sf-21 cells as well as with the mixture Cyt2Ba/
Cry4Aa in lepidopteran Bm5 cells. These data indicate synergism
between the Cyt and Cry toxins tested, which agrees with other
works showing this kind of interaction [33,16]. Weak additive
effects (SF , 1) were obtained for the Cyt2Ba/Cry11A mixture
when it was tested against lepidopteran Ld cells. Similar SF values
were detected after incubation of Cyt2Ba/Cry4Aa with C6/36
and Sf-21 cells. It was also demonstrated that some antagonism
(SF lower than 1) may occur between Cyt and Cry toxins
depending on the cell line tested. SF ,1 was observed for the
Cyt2Ba/Cry11A mixture in Bm5 cells and for Cyt2Ba/Cry4Aa in
Ld cells. Hughes et al. [34] also showed slight antagonism in vivo
when Cry11A and Cry4B were assayed in combination with
Cyt1A against Chironomus tepperi (Diptera: Chironomidae). Aside
from this report, it has been demonstrated that binding of
Cry11Aa to A. aegypti membranes is greatly enhanced by
preincubation of ‘‘brush border membrane vesicles’’ (BBMVs)
with Cyt1A [17]. Except for the C6/36 cells, our combination of
the three toxins (Cyt2Ba, Cry4Aa and Cry11A) led to a decrease of
the toxic activity in relation to the Cry11A and Cyt2Ba mixture
(Figure 2D). These results indicate that Cyt2Ba acts as a receptor
for both Cry toxins, as shown by Pe´rez et al. [17], and Cry4Aa
competes with Cry11A for the binding to Cyt2Ba, leading to
a weaker interaction than that of Cyt2Ba and Cry11A. There is
also evidence that Cry toxins may interact, forming hetero-
oligomers in vivo [35]. In our work, such molecular interactions
between Cry toxins could be more or less effective depending on
the cell line tested, after the putative binding of Cry toxins to
Cyt2Ba. This may explain why the cytotoxicity of the three toxins
together did not decrease in C6/36 in contrast to the other insect
cell lines.
Cry4Aa and Cry11A Toxic Activity When Processed by
Lepidopteran Gastric Juice
The Cry4Aa and Cry11A protoxins were also processed by
proteases found in the gastric juice extracted from S. frugiperda
larvae. As previously described, besides the three-domain based
structure and the intrinsic amino acid sequence, proteolytic
activation is a relevant factor for the toxicity of Cry toxins
[36,37]. The same incubation conditions as well as the protein
ratio used for trypsin activation were maintained for gastric juice
(GJ) protein processing. The cleavage pattern obtained for Cry4Aa
and Cry11A after incubation with S. frugiperda midgut proteases
resulted in a different SDS-PAGE banding profile than with
trypsin activation (Figure 3). According to Christeller et al. [38], the
GJ from different lepidopteran larvae contain predominantly
alkaline proteases with different patterns of trypsin- or chymo-
trypsin-like activities. Although both types of proteases are
members of the serine protease group, Cry proteins may undergo
different proteolytic processing upon trypsin or chymotrypsin
treatment. For instance, Cry3Aa toxin produced different poly-
peptides after treatment with each protease, but retained its ability
Table 1. Cytotoxicity of mixtures of Cry and Cyt toxins of Bacillus thuringiensis subsp. israelensis to insect cell lines.
Cry4Aa/Cry11A Cyt2Ba/Cry11A Cyt2Ba/Cry4Aa
LC50
a (95% limits) S.b X2c LC50
a (95% limits) S.b X2c LC50
a (95% limits) S.b X2c
C6/36 59.46 (49.48–80.261) 2.07 0.77 61.44 (53.27–74.65) 2.44 2.30 78.96 (66.60–105.51) 2.52 2.17
Bm5 111.65 (99.23–132.47) 3.29 1.34 147.03 (93.77–618.44) 1.45 0.68 59.93 (46.96–92.23) 2.47 3.31
Ld 108.97 (78.45–274.18) 2.07 4.40 54.79 (43.11–78.29) 2.50 3.62 106.47 (79.75–200.03) 1.81 1.30
Sf 75. 85 (50.66–119.51) 2.20 4.30 55.47 (44.41–76.275) 2.63 3.31 97.45 (73.02–175.76) 1.68 1.76













C6/36 59.46 77.70 1.30 61.44 74.92 1.21 78.96 81.54 1.03
Bm5 111.65 100.7 0.89 147.03 95.67 0.65 59.93 91.94 1.53
Ld 108.97 65.47 0.60 54.79 55.45 1.01 106.47 89.64 0.84
Sf 75. 85 75.85 1.10 55.47 76.45 1.37 97.45 97.48 1.01
a-observed mean lethal concentration (mg/mL).
b-expected mean lethal concentration (mg/mL).
c-synergism factor.
doi:10.1371/journal.pone.0046121.t002
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to bind Colorado potato beetle’s (Leptinotarsa decemlineata) BBMVs.
In contrast, the Cry3Ba toxin was unable to bind L. decemlineata’s
BBMVs using identical proteolytic treatments [39]. In our work,
the processed toxins were dialyzed and incubated with insect cell
cultures at a concentration of 20 mg/mL. To ensure that neither
trypsin nor GJ was responsible for any toxic activity to the cells,
cytotoxicity was measured after incubation of both proteases with
the cell lines. No cytotoxicity was detected for the processed Cry
toxins or for the protease samples (data not shown). Furthermore,
Cry11A and Cry4Aa crystals and GJ-activated proteins (20 mg/
mL) were also tested in vivo against second-instar larvae of A.
aegypti. Cry11A and Cry4Aa were toxic to A. aegypti larvae with
LC50 values of 53.72 ng/mL and 92.24 ng/mL, respectively
(Table 3). In contrast, no toxic activity was observed for the one-
dose bioassay using GJ- activated proteins (data not shown). It is
possible that the new cleavage pattern yielded by the lepidopteran
gastric juice does not provide a functional structure of an active
toxin [25]. However, we cannot rule out the possibility that Cry
proteins were overdigested by insect gastric juice and consequently
inactivated the toxins.
Cytotoxic Activity of Cry4Aa, Cry11A and Cyt2Ba to
a Mammalian Cell Line
The specificity of Cry proteins is also due to the fact that, when
ingested by susceptible insect larvae, each toxin binds to specific
receptors on the midgut epithelial cell brush border membrane
[40]. Thomas and Ellar showed that the pool of purified and
solubilized crystal proteins of Bti was toxic to mouse fibroblasts,
primary pig lymphocytes and mouse epithelial carcinoma cell lines
[12]. To determine whether the dipteran-specific toxins, Cry4Aa
and Cry11A, are toxic to mammalian cells via trypsin activation,
we performed cytotoxicity assays with human breast cancer cells,
MCF-7 (Figure 4). Some Bt strains have been reported to produce
parasporal proteins that are capable of discriminately killing
cancer cells [41,42]. However, this anticancer activity is achieved
by a different category of parasporal proteins, the so-called
parasporins, which exhibit very low homologies (,25%) to Cry
and Cyt proteins [42,43]. Since the wild type Bti d-endotoxins
used here as our positive reference control did not yield 100%
mortality when observed by light microscopy, a lysis buffer was
added to the cell culture so that all cells were lysed and a reliable
reference value was obtained by luminometric reading. No
cytotoxicity was detected when any of the Cry4Aa and Cry11A-
activated toxins were incubated individually or in combination
with the human cells. Mammalian cells do not display receptors
for the binding of Cry toxins on their surfaces, which may explain
why Bt is not toxic to mammals. In addition, the Cyt2Ba toxin was
incubated at two different concentrations with MCF-7 cells
(Figure 4). This experiment demonstrated that Cyt2Ba was
cytotoxic only at the highest concentration used in our assays
(20 mg/mL). This toxicity is probably due to the ability of Cyt2Ba
to bind cell membranes without specific receptors. The activity
value shown for the activated toxins expressed by Bti, approx-
imately 70% (Figure 4), may be explained by the synergistic effects
among additional toxins in the Bti crystals [11]. (For instance,
Cyt1Aa has been shown to synergize Cry4 and Cry11 toxins in A.
aegypti gut cells [17].) To investigate this hypothesis, another
cytotoxic assay was carried out using 20 mg/m concentrations of
the three toxins (Figure 4) in combination. The mixture of Cry and
Cyt toxins showed higher toxicity to MCF-7 cells than Cyt2Ba
alone, but non-parametric variance analysis of the cytotoxicity
values demonstrated that there was no significant difference in
toxicity between Cyt2Ba alone and in combination with the two
Cry toxins. It is not clear whether the significantly higher cytotoxic
value obtained for a 60 min incubation period was due to the
combination of the three toxins. Despite the variance, the
cytotoxic effect measurements plotted in the graph (Figure 4)
suggest an interaction between the Cry toxins with Cyt2Ba. If this
is true, Cyt2Ba may be functioning as a receptor for Cry4Aa and
Cry11A, which could lead to pore formation in human cell
membranes. Further work is needed to characterize the toxicity
interactions between Cry and Cyt proteins in mammalian cells.
Conclusion
During evolution insects from different orders and species
developed differences in the enzymatic composition of gastric
juices in order to adapt to a wide variety of diets. Microorganisms
with entomopathogenic capabilities, such as Bt, may have co-
evolved to take advantage of digestive enzymes evolved in insect
midguts. The toxicity of Bt to insects is chiefly based on d-
endotoxins that must be processed correctly in the intestinal lumen
of susceptible insects. The specificity of Cry toxins is, in part, due
to the type of proteolytic cleavage that takes place in the insect
Figure 3. SDS-PAGE analysis of Cry4Aa and Cry11A proteolytic
activation. The solubilized Cry4Aa and Cry11A protoxins were
activated either by standard incubation using trypsin (T) or by using
S. frugiperda’ gastric juice (GJ). The processed proteins were stained
with Coomassie blue. Molecular masses in kDa are shown on the left
(Prestained Protein Molecular Weight Marker, Fermentas).
doi:10.1371/journal.pone.0046121.g003
Table 3. Toxicity of individual Cry proteins to second-instar
larvae of A.aegypti.
Toxin n* LC50 (95% limits)** s***
Cry11A 75 53.72 (25.13–86.54) 3.814
Cry4Aa 75 92.24 (55.64–123.58) 2.673
*: number of tested larvae;
**: mean lethal concentration for 50% of larvae exposed (mg/mL).
***s: standard deviation.
doi:10.1371/journal.pone.0046121.t003
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midgut, as well as to the presence of specific receptors on the
midgut epithelial cell membranes. In this research, the dipteran-
specific Cry4Aa and Cry11A were shown, as expected, to be non-
toxic to lepidopteran cells when activated with gut juices from S.
frugiperda. However, these toxins acquired toxicity to lepidopteran
cells after trypsin activation. These cell types appear, therefore, to
express receptors capable of binding to the trypsin-activated Cry
proteins used in this work. It is feasible that at least part of the
specific toxic activity to dipteran insects is a consequence of the
type of processing these toxins might have undergone in the insect
gut. To confirm this hypothesis, binding assays should be carried
out in future work. No toxicity of activated Cry4Aa and Cry11A
was detected for a mammalian cell line. On the other hand,
Cyt2Ba showed some toxicity to these cells, and in the presence of
Cry4Aa and Cry11A, the toxicity was increased but was not
statistically significant. Bti toxins are not expected to be harmful to
humans, even if swallowed, because the toxin crystals need a pH of
10 or higher to be solubilized, while the human stomach has a pH
of 1–3. Moreover, it is not plausible that the proteolytic pattern
could activate a Bti toxin or that the protein would have
a functional structure in a solution with such a low pH.
Materials and Methods
Bacteria and Eucaryotic Cells
The Brazilian Bacillus thuringiensis subsp. israelensis S-1989 and S-
1806 strains were obtained from the Bacillus spp. bank of Embrapa
Recursos Gene´ticos e Biotecnologia (Brası´lia, Brazil) as the source
of cyt2Ba, cry4Aa and cry11A genes. Lepidopteran cells from
Spodoptera frugiperda, IPLB-SF-21AE (primary explants of pupal
tissue) [44], were obtained from Dr. Lois Miller, University of
Georgia, US; Lymantria dispar, IPLB-LD-652Y (isolated from
ovaries of the gypsy moth) [45] and Bombyx mori, BM-5 (isolated
from ovaries of the silk worm) [46], were provided by Dr. Maria
Elita de Castro, EMBRAPA-CENARGEN-Laborato´rio de virus
de inseto, Brazil, The cells were maintained at 27uC in TC-100
medium supplemented with 10% bovine fetal serum (Gibco-BRL).
Aedes albopictus cells C6/36 (a clone [47] derived from the Singhs
hatched minced larvae cell culture), obtained from Dr. Antoˆnio
Chaib, Laborato´rio Central de Sau´de Pu´blica (LACEN-DF),
Brazil, were cultivated at 27uC in Leibowitz L15 medium,
supplemented with 10% bovine fetal serum (Gibco-BRL). Human
breast cancers cells MCF-7 [48], obtained from Laborato´rio de
Morfologia, Universidade de Brası´lia, Brazil, were cultivated in
DMEM (Sigma) medium supplemented with 10% bovine fetal
serum at 37uC and 5% CO2.
Construction of Expression Vectors for Bacillus
thuringiensis
Plasmid DNA from Bti strains S-1989 and S-1806 were
extracted by alkaline lysis [49]. The complete ORFs of cyt2Ba
and cry4Aa genes were amplified by PCR using DNA from the S-







same way, the complete ORF of the cry11A gene was obtained
from the S-1806 strain using specific oligonucleotides (cry11AFor-
ward-59-CAGGATCCATGAATTATATGG AAGAT-39;
cry11AReverse-59-CAGGATCCCTACTTTAGTAACGGATT-
39). BamHI restriction sites were added to the oligonucleotide
sequences (underlined text). The start codon of each gene is shown
in italics (ATG) and the 6xHis tag codons fused to the cyt2Ba gene
are shown in bold. To amplify the cyt2Ba, cry4Aa and cry11a genes,
different PCR programs were performed using the respective three
sets of oligonucleotides: cyt2Ba –94uC/5 min and 30 cycles of
94uC/1 min, 52uC/45 s, 72uC/1:30 min and a final extension of
72uC/7 min; cry4Aa –94uC/5 min and 35 cycles of 94uC/1 min,
53uC/1 min, 72uC/2:30 min and a final extension of 72uC/
7 min; and cry11A –94uC/5 min and 30 cycles of 94uC/1 min,
53uC/1 min, 72uC/1:30 min and a final extension of 72uC/
7 min. Amplified fragments were cloned into the pGem-THeasy
(Promega) vector, using Escherichia coli DH5-aH (Invitrogen) as
a host, following the manufacturer’s instruction. DNA from
recombinant plasmids was isolated [49] and sequenced (377-
Applied Bio-system). The resulting genetically modified plasmids,
pGemcyt2BaHis, pGemcry4Aa and pGemcry11A were digested
with BamHI, and then separated by electrophoresis in a 0.8%
agarose gel. Fragments of approximately 800, 3,500 and 1,900 bp,
corresponding to the cyt2Ba, cry4Aa and cry11 genes, respectively,
were purified using the GFXTM PCR DNA and Gel Band
Purification Kit (GE Healthcare). The three genes were then
separately cloned into the expression vector pSVP27A, kindly
Figure 4. In vitro analysis of Cry and Cyt toxicity to MCF-7
human cells. The percentage of cytotoxicity (cell mortality) was
obtained by luminometry for all assays. Individual trypsin-activated
Cry4Aa or Cry11A as well as the mixture of these two toxins were
incubated with MCF-7 cell cultures for 30 min. Cyt2Ba and isolated
crystals of Bti were activated by trypsin and assayed against MCF-7 cells
for 30 min. Combinations of the three trypsin activated toxins (Cry4Aa,
Cry11A and Cyt2Ba) were incubated with MCF-7 cells for two distinct
periods of time (30 and 60 min) and cytotoxicity was measured to verify
any variation of toxic activity related to time of incubation. Untreated
cells (control) were not incubated with any of the toxins. Concentra-
tions of toxins are in parentheses.
doi:10.1371/journal.pone.0046121.g004
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provided by Dr. David Ellar, University of Cambridge, UK
[50,51], and transformed into E. coli DH5-aH. The positive clones
were selected by ampicillin resistance in culture medium (100mg/
mL). The recombinant plasmids pSVP27Acyt2BaHis, pSVP27A-
cry4Aa and pSVP27Acry11A were isolated by alkaline lysis as
described in [49]. The cloning of each gene was confirmed by
restriction enzyme digestion followed by electrophoresis in agarose
gels as described above.
Expression, Purification and Solubilization of Cry and Cyt
Proteins
An acrystalliferous Bti strain, 4Q7, kindly provided by Dr. Colin
Berry, Cardiff University, UK, was used as a host for the
constructed plasmids. The Bti cells were transformed with the
recombinant plasmids pSVP27Acyt2BaHis, pSVP27Acry4Aa and
pSVP27Acry11A by electroporation as previously described [52]
with the following modifications. The electroporation parameters
were adjusted on the BTX Electro Cell ManipulatorTM 600
apparatus, using the following setup: 15 kV cm21, 200 V e 25 mF.
After electroporation, the cell suspensions were diluted in 1 mL
LB broth and incubated with agitation (200 rpm) for 2 h at 28uC.
After cell recovery by centrifugation, the pellets were resuspended
and incubated on L-agar with 10 mg mL21 chloramphenicol [48].
The positive clones were grown in selective NYSM media [53]
with 10 mg/mL chloramphenicol at 30uC for 72 h. After this
period, crystals and spores were separated in a discontinuous
sucrose gradient according to protocol described below and as
described elsewhere [12] with modifications. The bacterial
cultures were collected and centrifuged at 16,0006g for 20 min
and the supernatant was discarded. The pellets were resuspended
and washed in 60 mL of a solution containing 0.3 M NaCl,
0.01 M EDTA pH 8.0 and centrifuged at 16,0006g for 20 min.
This procedure was repeated twice; at the end of the third
centrifugation the supernatant was discarded and the pellets were
resuspended in 30 mL 1.0 mM PMSF. Fresh 1.0 mM PMSF
solution was used to wash the samples by centrifugation at
16,0006g for 20 min. The sediments were then resuspended in
TTN buffer (20 mM Tris HCl, 0.1% Triton X-100, 300 mM
NaCl, pH 7.2). The samples were centrifuged at 25,0006g for 1 h
in a sucrose gradient (84%, 79%, 72%, 67% and 54%). The
protein bands corresponding to Cry11A, Cry4Aa and Cyt2BaHis,
formed in the gradient, were collected and added to a 0.1% Triton
X-100 solution. A new centrifugation at 25,0006g for 45 min was
performed and the sediments were resuspended in 1,0 mM PMSF.
The crystals of Cyt2BaHis and Cry11A were solubilized in 0.1 M
Na2CO3, pH 10.5 at 37uC for 1 h. The Cry4Aa crystals were
solubilized in the same solution supplemented with the reducing
agent 0.2% b-mercapto-ethanol. Any insoluble material was
removed by centrifugation. The samples were neutralized with
0.1 M Tris-HCl pH 7.5 [54]. The 6xHis tag Cyt2Ba C-terminal
fused protein was further purified by affinity chromatography
using an agarose Ni-NTA column (The QIA expressionistTM,
QIAGEN), according to the manufacturers instruction, to remove
any contaminants. The Bti S-1989 strain was also grown in the
sporulation medium NYSM and the protein crystals were purified
in a sucrose gradient, as described above for the individual Cry
and Cyt proteins. The purified crystals were then solubilized with
0.2% b-mercapto-ethanol in 0.1 M Na2CO3, pH 10.5 solution at
37uC for 1 h and then neutralized with 0.1 M Tris-HCl, pH 7.5.
The samples were analysed by electrophoresis in a 12% SDS-
PAGE (Mini-protean II – Biorad), following the manufacturer’s
instruction.
Toxin Activation
The samples containing the solubilized protoxins were quanti-
fied by fluorospectrophotometry using the NanoDrop 3300
apparatus together with the Quant-ItTM Assay Kit (Invitrogen).
The individually purified Cry toxins were activated by two
methods. In the first method, the protoxins were incubated with
pancreatic bovine trypsin (Sigma) at a 10:1 ratio (w/w) for 2 h at
37uC. In the second activation method, the protease-containing
gastric juice was obtained from ten S. frugiperda midguts following
the procedure described in [55]. The Cry4Aa and Cry11A
protoxins were incubated with the gastric juice at a 10:1 ratio (w/
w) for 2 h at 37uC. The samples obtained from both activation
methods were dialyzed against distilled water using 0.025 mm
membrane discs (MilliporeTM) and analyzed in a 12% SDS-
PAGE. Purified Cyt2BaHis was also trypsin activated and dialyzed
in the same conditions described for the Cry proteins. Further-
more, western blot analysis to check the Cyt2BaHis protein
cleavage was carried out using a monoclonal anti-His antibody
(GE Healthcare), following the manufacturer’s instruction. The
solubilized wild type Bti protoxins were incubated with pancreatic
bovine trypsin (Sigma) only at a 10:1 (w/w) ratio for 2 h at 37uC,
for protein activation, and dialyzed as above.
Cytotoxicity Assays
The insect (IPLB-SF-21AE, IPLB-LD-652Y, BM-5, C6/36) and
mammalian (MCF-7) cell lines, grown in 25 cm2 TPP flasks
(Techno Plastic Products, Switzerland), were collected and added
to 96-well plates (104 cells/well). The culture medium of MCF-7
cells was removed and the cells washed with 1 mL PBS. A trypsin/
EDTA (0.05%) solution was added to the cells, incubated at 37uC
and 5% CO2 for 4 min and 1 mL of DMEM medium was added
to stop trypsinization. The loose cells were centrifuged at 1,0006g
for 3 min, resuspended in DMEM medium and added to 96-well
plates (104 cells/well). The activated Cyt2Ba, Cry4Aa and Cry11A
toxins were added to the wells at predetermined concentrations.
Cyt2Ba toxin was tested at two concentrations (5 or 20 mg/mL)
separately or in combination with the other toxins. Cry4Aa and
Cry11A toxins were used at the concentration of 20 mg/mL,
individually or in the presence or absence of Cyt2Ba. The pool of
wild type Bti activated toxins were incubated with all cell lines at
the concentration of 5 mg/mL. All toxins were also incubated, at
the mentioned concentrations, with different culture media in the
absence of cells. Trypsin and gastric juice were individually
incubated with C6/36 cells. All assays were carried out in
triplicate. The time of all incubations with the three toxins as well
as with the proteases, was 30 min. Furthermore, the culture media
were incubated with CellTiter-GloH Reagent from the CellTiter-
GloH Luminescent Cell Viability Assay kit (Promega) for 10 min to
quantify the amount of ATP released to the media. The
luminescence-based measurements were carried out in a Turner
TD20/20 luminometer, with the following setup: delay time 5 s,
integration time 20 s, sensitivity 50%.
Mosquito Larvae
Neonate larvae of A. aegypti from the Rockfeller strain were
provided by Embrapa Recursos Gene´ticos e Biotecnologia
(Brası´lia, Brazil). The larvae were reared at room temperature
(25uC) in autoclaved distilled water and fed on cat biscuit until
they reached second instar.
Bioassays
Sucrose-gradient isolated Cry11A and Cry4Aa crystals were
added separately to 100 mL sterile tap water in disposable plastic
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cups containing 20 second-instar A. aegypti larvae, and mosquito-
cidal activities were determined after 24 h [56]. Serial dilutions of
each crystal protein sample were used in the bioassays, and three
replicates were performed for the seven doses tested, as well as for
an untreated control group used as a negative control. The median
lethal concentration for exposed populations was determined
statistically by probit analysis using a program for PC (Polo Plus,
LeOra Software). A. aegypti larvae were also exposed to a single
dose of 20 mg/mL of each GJ-activated toxin (Cry11A and
Cry4Aa), following the same method of incubation described
above. All bioassays were performed in duplicate.
Evaluation of Synergism
In order to identify potential synergistic effects, experimental
LC50 (concentration of toxin responsible for 50% cell mortality) of
each individual toxin and of the toxin mixtures (Cry4Aa/Cry11A,
Cyt2Ba/Cry11A and Cyt2Ba/Cry4Aa) was estimated by probit
analysis [57], using Polo Plus. Six doses ranging from 1 to 60 mg/
mL of each toxin were incubated with insect cell lines following the
method used for the cytotoxicity assays described above. For the
Cry toxin mixture the ratio used was 1:1, while for the Cry/Cyt
mixtures the ratios were 0.8:0.2. Three replicates were assayed
with each dose. Synergistic interactions between the Cry toxins
and between the Cry/Cyt were evaluated by the ratios of the
theoretical LC50, obtained by Tabashnik’s equation [29], and the
observed LC50. When the ratio was .1, the toxin interaction was
considered to yield a synergistic effect as the toxicity was higher
than the value predicted from individual additive toxicity. A ratio
,1 meant that the interaction was antagonistic, whereas a ratio of
1 indicated only additive effects.
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